Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Brainfarma Industria Química e Farmacêutica S/A

Clinicaltrial registered5 Nov 2026

Brainfarma Industria Química e Farmacêutica S/A

5 Nov 2026: Trial registered · Cosmetic Efficacy Evaluation of Hydraporin AI Cream in Individuals With Atopic Dermatitis and Psoriasis. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
5 Nov 2026
Title
Cosmetic Efficacy Evaluation of Hydraporin AI Cream in Individuals With Atopic Dermatitis and Psoriasis
Conditions
Atopic Dermatitis, Psoriasis
Phase
Not applicable
Study Type
Interventional
Status
Not Yet Recruiting
Countries
Brazil
Country
Brazil
Reference
NCT07918560
Location
Brazil
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Brainfarma Industria Química e Farmacêutica S/A

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from Brazil

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.